New effective treatment for post surgical back pain

Published On 2018-10-14 13:40 GMT   |   Update On 2018-10-14 13:40 GMT

A new treatment could help those with post-surgical, chronic low back pain, according to preliminary studies utilizing a simple procedure to remove scar tissue or adhesions. The study is published in the journal Pain Medicine.


The study is significant as failed back surgery (continued low back and leg pain after surgery) is relatively common. With each reoperation, success, as defined by pain reduction, becomes less likely and most patients do not improve.


Although multimodal and multidisciplinary pain management for FBSS (failed back surgery syndrome) is best, a systematic review has suggested that medications and repeat surgery are less effective, whereas physical therapy and interventional procedures have greater efficacy.


Michael Perloff, assistant professor of neurology at Boston University School of Medicine, and colleagues performed the Simplified Epiduralysis After Laminectomy/fusion (or SEAL) on 30 patients who continued to experience low back and leg pain after back surgery. Short-to moderate-term pain relief was reported in 74 percent of these patients. Nearly 40 percent reported greater than 50 percent pain relief. After three years of follow-up, only one patient went on to repeat lumbar spine surgery.


Read Also: Low Back Pain mistreated globally against treatment guidelines : Lancet

The SEAL procedure uses a low-cost standard obstetric epidural kit to place the epidural (via catheter) near the post-surgical site. The goal is to break up scar tissue or adhesions that are pushing up against the nerves. There are more complex procedures and implantable devices that help failed back surgery, but the SEAL is less invasive and done in one outpatient visit.


"SEAL could be an efficacious intervention for failed back surgery with a simplified procedure, lower costs, shorter procedure times and minimal adverse events," explained Dr. Perloff.


Perloff cautions that these findings could have bias yet given their promising results a clinical trial is planned for next year.


For further reference log on to https://doi.org/10.1093/pm/pny195



Article Source : With inputs from Pain Medicine

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News